Acute Porphyria Drugs

Monograph

J01DD08 - Cefixime
Propably not porphyrinogenic
PNP

Rationale
Probably not significantly metabolised. Conflicting references.
Chemical description
Perorally administered cephalosporin (200 mg x 2) used in pharyngotonsillitis, otitis media and sinusitis where treatment with penicillins have shown to be without effect. About 20 % of an oral dose (or 50 % of the absorbed dose) is excreted unchanged in urine within 24 hours. Up to 60% may be eliminated by non-renal mechanisms. There is no evidence of metabolism but some of the drug is probabably ecreted via bile. South African list: use with caution . French list: use.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes J01D / J01DD or go back.
References
Tradenames

Cefixima · Denvar Cefixim · Cefixime · Sufixin Forte · Suprax · Xifia Cefixima · Cefixoral · Stadium · Supracef · Unixime Cefixima · Eficef · Xifia Cefixime · Suprax · Suprax Paediatric Infecto-Opticef Cetix Cefixime Cefapan · Pancef Pancef Cefixime · Cefspan · Oroken · Suprax Cefixima Cefixime
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙